首页> 美国卫生研究院文献>other >Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells
【2h】

Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells

机译:脂质体是杆和环的不同亚细胞结构与MAP2和视网膜细胞的核包膜结构相关。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

“Rods and rings” (RR) and loukoumasomes are similarly shaped, subcellular macromolecular structures with as yet unknown function. RR, so named because of their shape, are formed in response to inhibition in the GTP or CTP synthetic pathways and are highly enriched in the two key enzymes of the nucleotide synthetic pathway. Loukoumasomes also occur as linear and toroidal bodies and were initially inferred to be the same as RR, largely due to their shared shape and size and the fact that it was unclear if they shared the same subcomponents. In human retinoblastoma tissue and cells we have observed toroidal, perinuclear, macromolecular structures of similar size and antigenicity to those previously reported in neurons (neuronal-loukoumasomes). To further characterize the subcomponents of the retinal-loukoumasomes, confocal analysis following immunocytochemical staining for alpha-tubulin, beta-III tubulin and detyrosinated tubulin was performed. These studies indicate that retinal-loukoumasomes are enriched for beta-III tubulin and other tubulins associated with microtubules. Immunofluorescence together with the in situ proximity ligation assay (PLA), confirmed that beta-III tubulin colocalized with detyrosinated tubulin within loukoumasomes. Our results indicate that these tissues contain only loukoumasomes because these macromolecular structures are immunoreactive with an anti-tubulin antibody but are not recognized by the prototype anti-RR/inosine monophosphate dehydrogenase (IMPDH) antibody (It2006). To further compare the RR and retinal-loukoumasomes, retinoblastoma cells were exposed to the IMPDH-inhibitor ribavirin, a drug known to induce the formation of RR. In contrast to RR, the production of retinal-loukoumasomes was unaffected. Coimmunostaining of Y79 cells for beta-III tubulin and IMPDH indicate that these cells, when treated with ribavirin, can contain both retinal-loukoumasomes and RR and that these structures are antigenically distinct. Subcellular fractionation studies indicate that ribavirin increased the RR subcomponent, IMPDH, in the nuclear fraction of Y79 cells from 21.3 ± 5.8% (0 mM ribavirin) to 122.8 ± 7.9% (1 mM ribavirin) while the subcellular localization of the retinal-loukoumasome subcomponent tubulin went unaltered. Further characterization of retinal-loukoumasomes in retinoblastoma cells reveals that they are intimately associated with lamin folds within the nuclear envelope. Using immunofluorescence and the in situ PLA in this cell type, we have observed colocalization of beta-III tubulin with MAP2. As MAP2 is a microtubule-associated protein implicated in microtubule crosslinking, this supports a role for microtubule crosslinkers in the formation of retinal-loukoumasomes. Together, these results suggest that loukoumasomes and RR are distinct subcellular macromolecular structures, formed by different cellular processes and that there are other loukoumasome-like structures within retinal tissues and cells.
机译:“杆和环”(RR)和小核小体是形状相似的亚细胞大分子结构,其功能尚不清楚。 RR,由于其形状而得名,是响应GTP或CTP合成途径中的抑制作用而形成的,并且高度富含核苷酸合成途径的两种关键酶。脂质体也以线性和环状体的形式出现,最初被认为与RR相同,这主要是由于它们共有的形状和大小,以及不清楚它们是否共享相同的子成分这一事实。在人类视网膜母细胞瘤组织和细胞中,我们观察到了环形,核周,大分子结构,其大小和抗原性与先前在神经元(神经细胞-神经小球蛋白)中报道的相似。为了进一步表征视网膜-淋巴小体的亚成分,在免疫细胞化学染色后对α-微管蛋白,β-III微管蛋白和脱酪氨酸微管蛋白进行了共聚焦分析。这些研究表明,视网膜淋巴小球体富含β-III微管蛋白和其他与微管相关的微管蛋白。免疫荧光与原位邻近结扎分析(PLA)一起证实,β-III微管蛋白与脱酪氨酸微管蛋白共定位在Loukoumasome中。我们的结果表明,这些组织仅包含淋巴小球体,因为这些大分子结构与抗微管蛋白抗体具有免疫反应性,但原型抗RR /肌苷单磷酸脱氢酶(IMPDH)抗体无法识别(It2006)。为了进一步比较RR和视网膜淋巴瘤小体,将成视网膜细胞瘤细胞暴露于IMPDH抑制剂利巴韦林(一种已知诱导RR形成的药物)中。与RR相反,视网膜淋巴小球体的产生不受影响。 Y79细胞针对β-III微管蛋白和IMPDH的免疫共染色表明,当用利巴韦林处理时,这些细胞可同时含有视网膜-淋巴小体和RR,并且这些结构在抗原上是不同的。亚细胞分级研究表明,利巴韦林将Y79细胞核部分中的RR子成分IMPDH从21.3±5.8%(0 mM利巴韦林)增加到122.8±7.9%(1 mM利巴韦林),而视网膜-淋巴小球蛋白亚成分的亚细胞定位微管蛋白保持不变。视网膜母细胞瘤细胞中视网膜-视网膜小球体的进一步特征表明,它们与核膜内的层状折叠密切相关。使用免疫荧光和这种细胞类型的原位PLA,我们已经观察到β-III微管蛋白与MAP2的共定位。由于MAP2是与微管交联有关的微管相关蛋白,因此支持微管交联剂在视网膜-淋巴小体的形成中的作用。在一起,这些结果表明,loukoumasomes和RR是不同的亚细胞大分子结构,由不同的细胞过程形成,并且在视网膜组织和细胞内还有其他Loukoumasome样的结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号